Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Market capitalisation, EUR | 14,160 m |
| EPS, EUR | 12.43 |
| P/B ratio | 3.4 |
| P/E ratio | 17.6 |
| Dividend yield | 0.00% |
| Revenue, EUR | 3,783 m |
| Net income, EUR | -316 m |
| Profit margin | -8.35% |
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 1.02% | Equity United States Health Care Biotech | 73 |
| Vanguard FTSE Global Small-Cap UCITS ETF USD Dist | 0.13% | Equity World Small Cap | 10 |
| Vanguard Russell 1000 U.S. Value UCITS ETF USD Dist | 0.04% | Equity United States Value | 1 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.02% | Equity World Social/Environmental | 579 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.02% | Equity North America Social/Environmental | 31 |
| Vanguard Russell U.S. Mid-Cap UCITS ETF USD Dist | 0.11% | Equity United States Mid Cap | 3 |
| JPMorgan Global Equity Active UCITS ETF USD (dist) | 0.50% | Equity World Social/Environmental | 1 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.22% | Equity United States Small Cap | 230 |
| Vanguard FTSE Global All-Cap UCITS ETF USD Dist | 0.01% | Equity World | 87 |
| YTD | +37.40% |
| 1 month | -3.96% |
| 3 months | -8.79% |
| 6 months | +18.15% |
| 1 year | +67.41% |
| 3 years | +63.88% |
| 5 years | +68.40% |
| Since inception (MAX) | +102.43% |
| 2025 | +23.85% |
| 2024 | +4.51% |
| 2023 | -24.44% |
| 2022 | +27.06% |
| Volatility 1 year | 36.33% |
| Volatility 3 years | 33.83% |
| Volatility 5 years | 31.01% |
| Return per risk 1 year | 1.86 |
| Return per risk 3 years | 0.53 |
| Return per risk 5 years | 0.35 |
| Maximum drawdown 1 year | -12.73% |
| Maximum drawdown 3 years | -37.14% |
| Maximum drawdown 5 years | -46.60% |
| Maximum drawdown since inception | -46.60% |